Enanta Pharmaceuticals
ENTA
#7441
Rank
HK$3.30 B
Marketcap
HK$114.63
Share price
4.17%
Change (1 day)
134.39%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: HK$3.30 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of HK$3.30 Billion. This makes Enanta Pharmaceuticals the world's 7441th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$3.30 B234.56%
2024HK$0.98 B-36.1%
2023HK$1.54 B-79.53%
2022HK$7.55 B-36.78%
2021HK$11.95 B82.46%
2020HK$6.55 B-31.25%
2019HK$9.53 B-11.58%
2018HK$10.77 B22.94%
2017HK$8.76 B77.28%
2016HK$4.94 B2.83%
2015HK$4.81 B-34.48%
2014HK$7.34 B93.17%
2013HK$3.80 B

End of Day market cap according to different sources

On Dec 12th, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

HK$3.30 Billion
by Nasdaq info icon info icon
HK$3.30 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
HK$3.071 T 92,736.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$3.966 T 119,802.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$901.92 B 27,160.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$1.949 T 58,827.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$830.29 B 24,995.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$1.979 T 59,732.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland